SC
ELV icon

Samlyn Capital’s Elevance Health ELV Stock Holding History

Samlyn Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-124,507
Closed -$54.2M – 96
2023
Q3 		$54.2M Buy
124,507
+2,253
+2% +$1.02M 0.89% 37
2023
Q2 		$54.3M Buy
122,254
+85,253
+230% +$39.3M 0.92% 41
2023
Q1 		$17M Buy
+37,001
New +$17.6M 0.31% 66
2019
Q1 		– Sell
-252,495
Closed -$66.3M – 115
2018
Q4 		$66.3M Buy
+252,495
New +$69.4M 1.58% 23
2018
Q3 		– Sell
-172,078
Closed -$41M – 139
2018
Q2 		$41M Buy
+172,078
New +$39.8M 0.96% 35
2016
Q2 		– Sell
-246,647
Closed -$34.3M – 122
2016
Q1 		$34.3M Buy
+246,647
New +$33M 0.74% 53

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Samlyn Capital's ELV Position: Q4 2023 in Review

Samlyn Capital sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 124,507 shares — an estimated $54.2M sold.

Samlyn Capital first reported a position in ELV in Q1 2016 and held it in 6 quarters. The position peaked at $66.3M in Q4 2018. 1,657 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Samlyn Capital reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Samlyn Capital sold 124,507 Elevance Health shares in Q4 2023, an estimated $54.2M.
  • Samlyn Capital first reported a position in Elevance Health in Q1 2016 and held it in 6 quarters.
  • Samlyn Capital's Elevance Health position peaked at $66.3M in Q4 2018.
  • 1,657 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Samlyn Capital's 13F filing for Q4 2023, filed 14 Feb 2024.